DNAnexus released that Fore Genomics will use the DNAnexus platform for its FORESITE 360 tests. The scalable DNAnexus platform allows Fore Genomics to meet current and future security, quality, and compliance requirements for the future.
The FORESITE 360 test is a health information service that creates a genomic profile using a baby’s DNA.
After the analysis, the approach offers a good understanding of current medical challenges, insights to guide preventive healthcare decisions, and serious information for relatives and future generations.
DNAnexus covers more than 40,000 registered users across 48 countries. They actively manage and support over 80 petabytes of complex genomic, proteomic, multi-omic, and datasets.
Read More: Fore Genomics Adopts DNAnexus Platform to Access and Analyze Whole-Genome Newborn Screening Data
